Literature DB >> 16859281

Decompressive craniectomy for space-occupying supratentorial infarction: rationale, indications, and outcome.

D J Lanzino1, G Lanzino.   

Abstract

A subset of patients with ischemic cerebrovascular stroke suffer a progressive deterioration secondary to massive cerebral ischemia, edema, and increased intracranial pressure (ICP). The evolution is often fatal. In these patients, a decompressive craniectomy converts the closed, rigid cranial vault into an "open box." The result is a dramatic decrease in ICP and a reversal of the clinical and radiological signs of herniation. For these reasons, decompressive craniectomy has been increasingly proposed as a life-saving measure in patients with large, space-occupying hemispheric infarction. The authors review the rationale, indications, and clinical experience with this procedure, which has been performed in patients who have had supratentorial ischemic stroke.

Entities:  

Mesh:

Year:  2000        PMID: 16859281     DOI: 10.3171/foc.2000.8.5.3

Source DB:  PubMed          Journal:  Neurosurg Focus        ISSN: 1092-0684            Impact factor:   4.047


  3 in total

1.  Prospective assessment of activities of daily living using modified Barthel's Index in children and young adults with low-grade gliomas treated with stereotactic conformal radiotherapy.

Authors:  Rakesh Jalali; Debnarayan Dutta; Rashmi Kamble; Tejpal Gupta; Anusheel Munshi; Rajiv Sarin; Ketayun Dinshaw
Journal:  J Neurooncol       Date:  2008-08-14       Impact factor: 4.130

2.  A Faster and Wider Skin Incision Technique for Decompressive Craniectomy: n-Shaped Incision for Decompressive Craniectomy.

Authors:  Ho Seung Yang; Dongkeun Hyun; Chang Hyun Oh; Yu Shik Shim; Hyeonseon Park; Eunyoung Kim
Journal:  Korean J Neurotrauma       Date:  2016-10-31

Review 3.  Acute supratentorial ischemic stroke: when surgery is mandatory.

Authors:  Gabriele Ronchetti; Pier Paolo Panciani; Roberto Stefini; Giannantonio Spena; Marco Maria Fontanella
Journal:  Biomed Res Int       Date:  2014-01-14       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.